Biomarker Analysis Contextualizes RFS Benefit With Nivolumab in Metastatic Melanoma
Brian Gastman MD,
United States Castle Biosciences Beachwood Family Health Center Risk Skin Cancer Program Department Of Plastic Surgery Brian Gastman
Source: onclive.com